ClinicalTrials.Veeva

Menu

A Virtually Delivered Exercise Intervention To Mitigate Cognitive Deficits From Radiotherapy In AYAs With Brain Tumors

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Terminated

Conditions

Brain Tumor
Brain Cancer

Treatments

Behavioral: Virtual Exercise Program
Behavioral: Standard Fitbit Program

Study type

Interventional

Funder types

Other

Identifiers

NCT05554159
NCI-2022-08000 (Other Identifier)
2022-0152

Details and patient eligibility

About

To test a new investigational virtual exercise program for adolescents and young adults (AYAs) with brain tumors who plan to receive cranial radiotherapy

Full description

Primary Objective:

Determine the feasibility and acceptability of a virtually supervised exercise intervention compared to control in AYAs with brain tumors undergoing cranial radiotherapy (CRT).

Secondary Objective:

Assess the effect of supervised exercise intervention on the neuroanatomic structure and cognitive function changes in AYAs with brain tumors undergoing CRT.

Exploratory Objective:

Assess the effect of supervised exercise intervention on other brain structure (white matter integrity), cognitive functions (attention, visual learning, psychomotor function, executive function, verbal learning, working memory and clinician-reported neurological exam outcomes), patient-reported health-related quality of life, objectively measured and patient-reported physical activity level, patient-reported dietary recall, objectively measured physical function assessments, and exercise progression (exercise volume). Assess the agreement between physical function tests performed twice virtually.

Enrollment

10 patients

Sex

All

Ages

15 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 15-39 years old
  2. Self-reported diagnosis of a primary benign or malignant brain tumor or confirmed diagnosis of primary benign or malignant brain tumor radiographically or pathologically when available (relapse or newly diagnosed)
  3. Plans to receive CRT at MDACC or, if the participant has already started CRT, the participant is eligible if they are within 3 weeks of the start of CRT
  4. Received appropriate physician clearance
  5. Able to move arms and legs, and ambulate safely
  6. Participant is insufficiently active (reports less than 150 minutes of planned moderate-vigorous intensity activity per week in the prior week)
  7. Participants and/or guardians are willing and able to provide informed consent
  8. Has a smartphone with available space to download additional apps
  9. Does not have sensorimotor strip impairment as indicated by the clinical team
  10. Has internet access
  11. Can receive physical therapy because this is part of the standard of care
  12. Participants and/or guardians are willing and able to provide informed consent for protocol PA18-0130 (Pediatric Energy Balance Data Repository Study), companion protocol for the Fitbit application/assessment.

Exclusion criteria

  1. Non-English speaking
  2. Screen failure for exercise safety based on Physical Activity Readiness Questionnaire (PAR-Q).12
  3. Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease
  4. Recent fracture or acute musculoskeletal injury that precludes ability to participate in supervised exercise training sessions
  5. Cognitive and/or major sensory deficits that would impede the completion of research activities and assessments as deemed by the clinical team.
  6. Self-reported diagnosis of a metastatic brain tumor or confirmed diagnosis of a metastatic brain tumor radiographically or pathologically when available
  7. Self-report of pregnancy
  8. Currently enrolled in another physical activity or exercise intervention
  9. Prisoners
  10. Self-reported pregnancy status

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Actigraph
Experimental group
Description:
A device worn on the waist that measures physical activity (such as the number of steps participants walk each day, how long participants spend standing, and how long partticipants spend laying down). Participants should wear the ActiGraph at least 10 hours a day for 7 days.
Treatment:
Behavioral: Virtual Exercise Program
Behavioral: Standard Fitbit Program

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Keri L Schadler, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems